Filter
742
Filtered Results: 742
Text search:
Condiciones
genéticas
Featured
Recommendations
53
New Publications
143
Language
Document type
No document type
371
Studies & Reports
149
Guidelines
122
Manuals
56
Strategic & Response Plan
22
Training Material
10
Fact sheets
9
Online Courses
2
Situation Updates
1
Countries / Regions
Global
40
India
38
Latin America and the Carribbean
19
South Africa
17
Kenya
15
Philippines
12
Africa
10
Western and Central Europe
9
Ethiopia
9
Uganda
8
Nigeria
7
Tanzania
7
Nepal
6
Ghana
6
Rwanda
6
Brazil
6
Namibia
6
Liberia
6
Ukraine
5
Venezuela
5
Congo, Democratic Republic of
5
Paraguay
5
Zambia
5
Sierra Leone
4
Peru
4
Malawi
4
Asia
4
West and Central Africa
4
East and Southern Africa
4
Argentina
4
Bangladesh
4
Ecuador
4
Myanmar / Burma
4
Colombia
3
Lesotho
3
Chile
3
Syria
3
Germany
3
Angola
3
Indonesia
3
Canada
2
Senegal
2
Afghanistan
2
Zimbabwe
2
Guinea
2
Mozambique
2
Haiti
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Russia
2
Mexico
1
Kazakhstan
1
Cameroon
1
Albania
1
Singapore
1
Burkina Faso
1
USA
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Central African Republic
1
Honduras
1
Mali
1
Chad
1
Botswana
1
Madagascar
1
Eswatini/ Swaziland
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
218
Clinical Guidelines
67
Public Health
61
Women & Child Health
26
Pharmacy & Technologies
26
Key Resources
16
Capacity Building
10
Toolboxes
Mental Health
111
COVID-19
43
Planetary Health
41
AMR
39
NTDs
37
TB
36
Pharmacy
33
NCDs
33
Rapid Response
26
HIV
23
Caregiver
18
Disability
16
Global Health Education
13
Ebola & Marburg
11
Specific Hazards
8
Conflict
8
Zika
8
Polio
8
Refugee
5
Health Financing Toolbox
4
Cholera
3
Natural Hazards
2
Social Ethics
2
Malaria
1
In sum, the goal is to understand the need to increase fiscal space for health as a prerequisite, but within the framework of efforts to transform the health system. These changes should foster equitable and efficient expenditures and create or strengthen comprehensive integrated health systems with...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
The purpose of this guidance is to provide emergency planners with nuclear detonationspecific
response recommendations to maximize the preservation of life in the event of
an urban nuclear detonation. This guidance addresses the unique effects and impacts of a
nuclear detonation such as scale of ...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Energy use in the home is a vital and ubiquitous feature of human society. Energy
is used for a wide variety of purposes, including cooking, space heating, light-
ing, small-scale income generation, various household tasks, and entertainment.
Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained settings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Quality of care in fragile, conflict-affected and vulnerable settings: tools and resources compendium
recommended
This compendium represents a curated, pragmatic and non-prescriptive collection of tools and resources to support the implementation of interventions to improve quality of care in such contexts. Relevant tools and resources are listed under five areas: Ensuring access and basic infrastructure for qu...
Four simple steps to practice quality improvement at health facility level
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Second Edition
AIDS Medicines and diagnostics services
July 2015
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
